Wooten

Edward Wooten and Sarkis Oganyan, individually and on behalf of all others similarly situated v. BioLife Plasma Services L.P. and Takeda Pharmaceuticals U.S.A., Inc.

Good Law
United States District Court, Eastern District of CaliforniaOctober 22, 20251:25-cv-00099California2,959 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF CALIFORNIA 8 EDWARD WOOTEN and SARKIS No. 1:25-cv-00099-KES-SKO OGANYAN, individually and on behalf of all others similarly situated, Plaintiffs, ORDER GRANTING DEFENDANTS’

MOTION TO DISMISS

v. Doc. 19 BIOLIFE PLASMA SERVICES L.P. and

TAKEDA PHARMACEUTICALS U.S.A.,

INC., Defendants.

17 Plaintiffs Evan Wooten and Sarkis Oganyan proceed on their first amended class action complaint (“FAC”), on behalf of themselves and others, against defendants BioLife Plasma Services L.P. (“BioLife”) and Takeda Pharmaceuticals U.S.A., Inc. (“Takeda”). Doc. 17 (“FAC”). Plaintiffs allege that, when they created accounts on BioLife’s website, third-party trackers installed by defendants, and operated by third-parties Snap and Salesforce, captured their email addresses and IP addresses without their consent, in violation of the California Invasion of Privacy Act (“CIPA”). Defendants move to dismiss the FAC pursuant to Federal Rules of Civil Procedure 12(b)(1), 12(b)(2), and…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.